↓ Cooling
Business
AstraZeneca and Ionis Stocks Sink on Trial Miss and Analysts See an Overreaction
AstraZeneca and Ionis face market volatility following the failure of their heart disease drug, Wainua, in a critical clinical trial.
1 trends tracked about this subject — the full history, oldest to newest below.
AstraZeneca and Ionis face market volatility following the failure of their heart disease drug, Wainua, in a critical clinical trial.